ENTITY
Illumina Inc

Illumina Inc (ILMN US)

91
Analysis
Health Care • United States
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
more
•20 Nov 2024 18:27

Quiddity Leaderboard S&P 500 Dec 24: APP, APO, and TPL May Be ADDs, Watch SP600 DELs

The S&P500/400/600 Dec24 review will be announced in just over 10 days. There is an intra-review change in SP600 first, and perhaps a few more in...

Logo
620 Views
Share
bullish•Illumina Inc
•15 Nov 2024 15:00

Illumina Inc.: These Are The 3 Biggest Challenges In Its Path! - Major Drivers

Illumina experienced a mixed third-quarter performance for 2024, illustrating both advancements and challenges in its operational landscape. The...

Logo
334 Views
Share
•26 Sep 2024 22:25

Nasdaq-100 December 2024 Forecasts: Monolithic Power & AppLovin It; Dollar Tree Needs Watering

​MPWR and APP are the top candidates for inclusion with an average forecasted demand at nearly $2bn and 3.5 ADV, while DLTR and ILMN face a high...

Share
•08 Sep 2024 21:38

S&P 500 September 2024 Forecasts: Dull for DELL. Brighter for ERIE, LII and TPL

ERIE, DELL and PLTR were the announced additions and the top migration and transition candidates. To improve convictions, transitions and...

Share
bullish•Illumina Inc
•17 Aug 2024 02:00

Illumina Inc.: The Tale Of Global Market Penetration and Expansion! - Major Drivers

In the second quarter of 2024, Illumina posted revenue results that exceeded expectations. While the revenue from core Illumina stood at $1.1...

Logo
479 Views
Share
x